Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab.
Onitilo
Adedayo A
AA
Engel
Jessica M
JM
Clouse
Lawrence H
LH
Gerndt
Kristin M
KM
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D016685:Mitomycin / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D016685:Mitomycin